Skip to main content
logo
Evopoint Biosciences Co., Ltd. (SHA:688837)
China flag China · Delayed Price · Currency is CNY
49.40
+5.79 (13.28%)
Sep 30, 2026, 3:00 PM CST

Evopoint Biosciences Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Revenue
1,111935.24--19.5
Revenue Growth
18.80%----
Gross Profit
1,111935.24--19.5
Operating Income
458.11210.11-462.1-450.16-522.56
Net Income
408.51202.56-386-426.89-462.63
Earnings Per Share
1.110.55-1.05-1.25-1.42
EPS Growth
100.91%----

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Investments
983.36818.39383.42530.47429.37
Total Debt
1,294898.25521.48412.22360.67
Net Cash (Debt)
-310.83-79.86-138.05118.2468.7
Net Cash Growth
---72.11%-
Net Cash Per Share
-0.84-0.22-0.380.350.21

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Operating Cash Flow
270.32178.3-349.49-370.55-418.55
Capital Expenditures
-58.59-62.64-50.08-90.13-162.2
Free Cash Flow
211.72115.66-399.57-460.68-580.75
Free Cash Flow Growth
83.05%----

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Gross Margin
100.00%100.00%--100.00%
Operating Margin
41.23%22.47%---2679.80%
Pretax Margin
46.66%31.57%---2372.47%
Profit Margin
36.77%21.66%---2372.47%
FCF Margin
19.06%12.37%---2978.22%